Reference:
1. Coronavirus disease (COVID-19): COVID-19 vaccines and people living with HIV. 2021. https://www.who.int/news-room/q-a-detail/coronavirus-disease-(covid-19)-covid-19-vaccines-and-people-living-with-hiv
2. Lavy I, Finesod A, Litchevsky V, Biber A, Indenbaum V, Olmer L, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1 [Internet]. 2021. https://papers.ssrn.com/sol3/ papers.cfm?abstract_id =3829650
3. Frater J, Ewer K, Obge A, Pace M, Adele S, Adland E, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. 2021. https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S235230182100103X?returnurl=https:%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS235230182100103X%3Fshowall%3Dtrue&referrer=
Keywords:
ยาต้านไวรัสเอชไอวี, วัคซีนโควิด-19